Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Their DeepMind synth proved to be a great, all-analogue success, but its eagerly awaited new version looks like a step ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). To learn more, check ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Nvidia has invested in a startup founded by a former Google DeepMind senior research scientist who specialized in robotics ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...